Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 USD | -0.53% | 0.00% | -4.12% |
Financials (USD)
Sales 2024 * | 206M | Sales 2025 * | 243M | Capitalization | 836M |
---|---|---|---|---|---|
Net income 2024 * | 19M | Net income 2025 * | 30M | EV / Sales 2024 * | 3.79 x |
Net cash position 2024 * | 56.01M | Net cash position 2025 * | 93.09M | EV / Sales 2025 * | 3.05 x |
P/E ratio 2024 * |
75.6
x | P/E ratio 2025 * |
44.7
x | Employees | 1,102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.86% |
Latest transcript on Enfusion, Inc.
1 day | -0.53% | ||
Current month | +0.54% | ||
1 month | +0.76% | ||
3 months | +7.14% | ||
6 months | +3.10% | ||
Current year | -4.12% |
Managers | Title | Age | Since |
---|---|---|---|
Oleg Movchan
FOU | Founder | 50 | 05-12-31 |
Bradley Herring
DFI | Director of Finance/CFO | 54 | 22-12-18 |
Dan Groman
CTO | Chief Tech/Sci/R&D Officer | 35 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen DeRose
BRD | Director/Board Member | 63 | 21-12-06 |
Brad Bernstein
BRD | Director/Board Member | 57 | 20-12-31 |
Director/Board Member | 63 | 19-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 9.3 | -0.53% | 256,905 |
24-04-23 | 9.35 | +1.30% | 552,040 |
24-04-22 | 9.23 | -0.11% | 239,902 |
24-04-19 | 9.24 | +1.43% | 212,938 |
24-04-18 | 9.11 | -2.04% | 253,228 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.12% | 840M | |
+8.78% | 3,028B | |
+2.45% | 80.47B | |
+1.94% | 76.81B | |
-11.97% | 54.2B | |
-16.33% | 51.74B | |
+25.74% | 47.88B | |
+16.44% | 39.62B | |
+56.22% | 35.14B | |
-11.26% | 24.18B |
- Stock Market
- Equities
- ENFN Stock